In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

E-Journal of Cardiology Practice

Consul the latest articles online for free and stay up to date on recent findings and best practices by subscribing to the emails alerts.

Access articles

Council for Cardiology Practice

The Council for Cardiology Practice is the ESC Constituent Body for office-based practicing general cardiologists.

Aortic stenosis

Webinar recordings

Aortic stenosis - evaluation of common to challenging cases

Watch the recording

This webinar was based on the presentation and discussion of two difficult clinical cases of AS patients. The first case was a patient with Low-Gradient symptomatic AS with an Aortic Area < 1 cm2. The discussion focused on the necessity to check for errors in measurement and correlation to body surface of the area. It was also discussed the need for further investigations such as an exercise test (not indicated in symptomatic but only in asymptomatic patients) In this case it is better to do a Dobutamine ECHO. Moreover were discussed the not utility of a TEE, while the measurement of calcium score with CT, and the measurement of LVOT diameter are important. The second case was a severe AS in an asymptomatic ‘lower’ risk patient with previous chest Radiotherapy for Hodgkin disease. The speakers also discussed the presence of symptoms and the related mortality and morbidity: prognosis is improved by treatment only when symptoms are present. Also if the higher the gradient, the higher the related event rates, an intervention in asymptomatic subjects has unproven results. If aortic calcification is present, TAVI is the better choice for intervention but mitral calcification may complicate TAVI with a poor outcome. However TAVI is to be preferred over surgical replacement (SAVR) in case of previous irradiation and thoracotomies, porcelain aorta, not relevant mitral regurgitation, patient wish.

Aortic stenosis in the 2017 new ESC Valvular Heart Disease Guidelines novelties to debate

Watch the recording

This webinar was broadcasted after the publication of the new version of the Valvular Heart Diseases (VHDs) Guidelines in August. Three clinical cases were discussed. The first case was a 40 year old pregnant female with Bicuspid Valve AS. Apparently the AS got worse; but in the presence of a condition of reversible high flow, which may elevate the valvular gradient, it is necessary to re-evaluate the AS after delivery. In severe AS, intervention should be guaranteed in presence of a low EF, symptoms or symptom development during an exercise test, and also marked BNP elevation and pulmonary hypertension development. In patients at low risk the SAVR is still the choice. The second case highlighted the essential role of the heart team for the management. The patient studied was very old, and presented a very high risk due to CAD, peripheral VD, PM for II BAV, COPD. The intervention choice was a trans-apical approach TAVI (he was not suitable for SAVR and not for trans-femoral TAVI approach). This case was very useful to discuss the issues in favour of the indication for TAVI vs SAVR. The third case was a very complex patient with a previous replacement of the aortic root and ascending aorta with severe Aortic Regurgitation, very low EF (20%), severe MR. In this very difficult and risky situation, an operation using a SAVR, and a mitral valve repair may be the solution. 

New mission statement

The mission of the Council for Cardiology Practice has been modified to: "Improve the standard of care in clinical cardiology practice of office based general cardiologists".

After long discussions, adjustments and modifications, the Council Nucleus has proposed modifications regarding its mission and audience. Finally, the nucleus has reached a new definition.

The Council for Cardiology Practice was created in 2000 to gather cardiologists working in private practice. Across the years, the Council welcomed new countries with different healthcare systems. Among them, colleagues working in an out of hospital setting, which was not ‘fully private’, with some kind of reimbursement directly or indirectly paid by the National Heart Service, became preponderant. The qualifying aspects of the cardiologists in practice are:

  1. profession mainly carried out in out of hospital offices and
  2. interest in ‘General Cardiology’.

So the Council decided to modify slightly but essentially its mission insisting less on the ‘private’ aspect and more on the profession.

The Council proposed these changes to the ESC Board and after many prolific discussions and corrections; we came up with a new definition of our mission statement.

So we, as general cardiologists, should ‘not know everything of something’, but ‘know something of everything’.

This will be our commitment for the next years.

Direct membership launch

As many other ESC Constituent Bodies, the Council for Cardiology Practice is now launching a simplified Direct Membership. Thus, general cardiologists who are not members of one of the national associations represented in the Council can become members.

The procedure to apply requires only a few minutes.

See here the benefits of your direct membership!

Be one of the first to join the Council for Cardiology Practice, your Council about general cardiology!

Join us

LinkedIn group for members

linkedin-logo.pngYes, we did it! In recent years, the European Society of Cardiology has relied more and more on social media to share knowledge and stimulate discussion. The Council for Cardiology Practice is now following this example and according to ESC rules, has opened a LinkedIn group for its members.

This platform is an opportunity to share your knowledge; to engage with the leaders of the Council for Cardiology Practice; to actively participate in conversations and spark new ideas and debates; create a long-lasting network with like-minded people.

We invite you to add value through your knowledge and to keep the conversations dynamic and fruitful so that the entire network can benefit from this unique sharing experience.

The goals of the CCP LinkedIn group are:

  • To communicate and receive feedback on the Council activities
  • To be a platform of discussion on topics of interest related to the Cardiology Practice field
  • To give the opportunity to know more about awards, conferences, grants in the field
  • To give access to free educational material (slides, surveys etc.)

Please note that the access to the LinkedIn group is a member benefit. Thus, you will have to log in to your My ESC Account to join the group.

Restricted content

Join the Council for Cardiology Practice now to share your knowledge and extend your network!

ESC Congress Resources

poster simple.JPG

Discover these special sessions on General Cardiology focussing on:

  • Hypertension and Prevention
  • Arrhythmias and Devices
  • Coronary Artery Diseases

Watch the presentations

Access all ESC Congress resources


CardioPulse article

An article about the Council for Cardiology Practice (CCP)

Read this CardioPulse article about CCP.

Eur Heart J (2016) 37(19): 1485-1492 DOI:

A review of the SPRINT Systolic Blood Pressure Intervention Trial

The Systolic Blood Pressure Intervention Trial (SPRINT) was designed to test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal (120mmHg) than currently recommended (140mmHg) could reduce cardiovascular disease (CVD) risk.

Dr. Marc Ferrini from the Council for Cardiology Practice has contributed this review of the Sprint Trial.

 ESC Guidelines

Here are the most recent ESC Guidelines.

Download ESC Guidelines

Atrial Fibrillation 2016 (Management of) download
Dyslipidaemias 2016 (Management of) download
Acute and Chronic Heart Failure download
Cancer treatments & cardiovascular toxicity 2016 (Position Paper) download
CVD Prevention in Clinical Practice (European Guidelines on) download


Access the full list of ESC Guidelines